Skip to main content
Equibles
CYTK logo

CYTK · Cytokinetics Inc · Metrics

Track CYTK — free

Use CYTK with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$75.35 +2.63 (+3.62%) At close · Sep 8
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$10.11B
Shares
139.02M

CYTK metrics

66 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$75.35
Market cap
$10.11B

Price action

20 metrics
Price change (1W)
+0.9%
Price change (30D)
-6.2%
Price change (3M)
+1.7%
Price change (6M)
+20.4%
Price change (YTD)
+14.4%
Price change (1Y)
+46.2%
Trailing year
Price change (5Y)
+124.0%
52-week high
$87.26
52-week low
$47.56
Change from 52-week high
-16.7%
Change from 52-week low
+52.9%
Annualized volatility
45.0%
Annualized volatility (3M)
37.9%
Beta
0.9
RSI (14D)
41.3
Price vs SMA 50
-8.2%
Price vs SMA 200
+4.2%
Avg volume (3M)
2.06M
Relative volume
0.6
Average dollar volume
$161.68M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
139.02M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
149.7×
reciprocal yield 0.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
149.4×
reciprocal yield 0.7%
P / book
—
FCF yield
-5.7%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-8.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
698.1×
reciprocal yield 0.1%
EV / revenue historical average (5Y)
531.8×
reciprocal yield 0.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
-1,046.1%
Trailing 12 months
Net margin
-1,321.1%
Gross profit (TTM)
—
Operating profit (TTM)
−$707.91M
Net income (TTM)
−$894.00M
Trailing 12 months
Diluted EPS (TTM)
$-7.23
FCF margin
-858.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.05

Growth

11 metrics
Revenue growth YoY
-57.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$67.67M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+10.6%
Year over year · more shares
Revenue CAGR (3Y)
-2.4%
Revenue CAGR (5Y)
+9.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-46.5%
Debt / equity
—
Current ratio
6.7
EBITDA (TTM)
−$695.36M
Free cash flow (TTM)
−$580.72M
Quick ratio
6.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$20.29M
Latest balance sheet
Cash & equivalents
$255.27M
Total assets
$1.92B
Total debt
$275.56M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$555.45M
Capital expenditures (TTM)
$25.26M
R&D (TTM)
$400.96M
SG&A (TTM)
—
Stock compensation (TTM)
$127.31M
R&D / revenue
592.5%
Stock compensation / revenue
188.1%

Ownership (13F)

3 metrics
13F filers
488
13F filer change QoQ
+36
Institutional ownership
120.7%

Short interest

3 metrics
Short interest
11.7%
Latest settlement · 7.7 days to cover
Days to cover
7.7d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$11.90M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1061983 CUSIP 23282W605 13F (30d) 305 filings 304 filers Visit website Investor relations